Riskpilot← Back to searchSign inGet full accessMG-Medical AB
ABActiveOrg 5566307004Dannemoragatan 8General medical practice activities · NACE 8621Est. 20021 employees
Revenue 2025
SEK 710K
-15% vs 2024
EBITDA margin
37.2%
-47% vs 2024
Equity ratio
95.4%
Financial strength
Net profit 2025
SEK 166K
-49% vs 2024
| Revenue | SEK 710K | -15% |
| EBITDA | SEK 264K | -47% |
| Net profit | SEK 166K | -49% |
| Total assets | SEK 5,1M | +0% |
| Equity | SEK 4,8M | -1% |
| Employees | 1 | — |
Legal name
MG-Medical AB
Org number
5566307004
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 augusti 2002
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinsk verksamhet såsom läkaruthyrning och konsultuppdrag, medicinsk- och företagshälsovårdsmottagning samt förvaltning av värdepapper. Handel med konst och antikviteter samt med sportbilar, veteranbilar och motorcyklar. Bolaget skall bedriva stuguthyrning och utöva travhästverksamhet och därmed förenlig verksamhet.
Address
Dannemoragatan 8
Phone
+46707993958
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 916 | 1 060 | 1 227 | 832 | 710 |
| Staff expenses | — | −253 | −221 | −234 | −335 |
| EBITDA | 242 | 622 | 715 | 503 | 264 |
| Depreciation & amort. | −2 | −0 | −42 | −72 | −72 |
| EBIT | 240 | 622 | 673 | 431 | 192 |
| Net financials | — | 11 | 78 | 119 | 86 |
| Profit before tax | 811 | 633 | 751 | 411 | 209 |
| Tax | −175 | −131 | −154 | −86 | −43 |
| Net profit | 636 | 503 | 596 | 325 | 166 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 091 | 4 427 | 4 793 | 5 055 | 5 056 |
| Equity | 4 033 | 4 345 | 4 747 | 4 872 | 4 823 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 58 | 82 | 46 | 45 | 26 |
| Total debt | 58 | 82 | 46 | 45 | 26 |
EBITDA margin
37.2%
This company
15.8%
Market median
+135% vs market
20212025
Equity ratio
95.4%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
23.4%
This company
8.1%
Market median
+189% vs market
20212025
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MG-Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna-Lena Maria Fridén | Deputy Board Member | 0 companies |
| Mats Karl Arne Gréen | Board of Directors | 0 companies |